Stonebridge Capital Advisors’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13
Closed -$73 220
2023
Q3
$73 Hold
13
﹤0.01% 911
2023
Q2
$66 Hold
13
﹤0.01% 915
2023
Q1
$87 Hold
13
﹤0.01% 924
2022
Q4
$115 Hold
13
﹤0.01% 935
2022
Q3
$0 Hold
13
﹤0.01% 991
2022
Q2
$0 Hold
13
﹤0.01% 906
2022
Q1
$0 Sell
13
-71
-85% -$3.01K ﹤0.01% 1006
2021
Q4
$5K Hold
84
﹤0.01% 722
2021
Q3
$6K Sell
84
-13
-13% -$924 ﹤0.01% 691
2021
Q2
$9K Buy
97
+84
+646% +$7.28K ﹤0.01% 755
2021
Q1
$1K Buy
+13
New +$1.45K ﹤0.01% 878
2020
Q3
Sell
-13
Closed -$2K 185
2020
Q2
$2K Hold
13
﹤0.01% 647
2020
Q1
$1K Sell
13
-130
-91% -$23.2K ﹤0.01% 683
2019
Q4
$37K Buy
143
+96
+204% +$35.8K 0.01% 361
2019
Q3
$25K Hold
47
﹤0.01% 411
2019
Q2
$44K Buy
+47
New +$47.2K 0.01% 338

Other funds holding ACB

Stonebridge Capital Advisors's ACB Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Aurora Cannabis (ACB) in Q4 2023, closing a stake of 13 shares — an estimated $73 sold.

Stonebridge Capital Advisors first reported a position in ACB in Q2 2019 and held it in 16 quarters. The position peaked at $44K in Q2 2019. 201 funds tracked by Wall St. Rank hold ACB as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Aurora Cannabis position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 13 Aurora Cannabis shares in Q4 2023, an estimated $73.
  • Stonebridge Capital Advisors first reported a position in Aurora Cannabis in Q2 2019 and held it in 16 quarters.
  • Stonebridge Capital Advisors's Aurora Cannabis position peaked at $44K in Q2 2019.
  • 201 funds tracked by Wall St. Rank held Aurora Cannabis as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.